Anti-DR5 antibody
4
(5 Reviews)
|
(64 Publications)
Rabbit Polyclonal DR5 antibody. Suitable for ICC, WB, IHC-P and reacts with Human, Mouse, Rat samples. Cited in 64 publications. Immunogen corresponding to Synthetic Peptide within Human TNFRSF10B.
View Alternative Names
CD262, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9, UNQ160/PRO186, TNFRSF10B, Tumor necrosis factor receptor superfamily member 10B, Death receptor 5, TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2
- ICC
Supplier Data
Immunocytochemistry - Anti-DR5 antibody (AB8416)
ICC analysis of 4% paraformaldehyde-fixed (room temperature for 10 minutes) HeLa cells labeling DR5 with ab8416 at 20μg/mL, followed by goat anti-rabbit IgG antibody (Alexa Fluor 488) at 1/500 dilution (green).
Blocking condition : 5% BSA, room temperature for 1 hour.
Primary antibody incubation : 4°C overnight.
Secondary antibody incubation : room temperature for 1 hour.
Washing condition : PBS, 3 x 3 minutes
- ICC
Unknown
Immunocytochemistry - Anti-DR5 antibody (AB8416)
ab8416 at 5μg/ml staining DR5 in Hela cells by ICC. Cells were fixed with formaldehyde and blocked with 10% serum for 1 hour at room termperature. Antigen retrieval was by heat mediation with a Citrate buffer (pH 6). Overnight primary antibody at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DR5 antibody (AB8416)
IHC-P of 4% paraformaldehyde-fixed rat brain tissue labelled DR5 with ab8416 at 5μg/ml, followed by Goat Anti-Rabbit IgG secondary antibody at 1/5000 dilution (green) and DAPI (blue).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DR5 antibody (AB8416)
Immunohistochemical analysis of 4% paraformaldehydefixed mouse kidney tissue using anti-DR5 antibody (ab8416) at 20μg/mL followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DR5 antibody (AB8416)
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue using anti-DR5 antibody (ab8416) at 5μg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation (microwave for 20 minutes) with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4˚C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary at room temperature for 1 hour. Counter stained with Hematoxylin.
Endogenous peroxidase blocking : 3% H202 at room temperature for 10 minutes.
Washing : PBS, 2 x 5 minutes.
- WB
Supplier Data
Western blot - Anti-DR5 antibody (AB8416)
All lanes:
Western blot - Anti-DR5 antibody (ab8416) at 0.5 µg/mL
Lane 1:
HEK293 cell lysate at 15 µg
Lane 2:
A431 cell lysate at 15 µg
Lane 3:
A549 cell lysate at 15 µg
Lane 4:
Caco-2 cell lysate at 15 µg
Lane 5:
Daudi cell lysate at 15 µg
Lane 6:
HeLa cell lysate at 15 µg
Lane 7:
HepG2 cell lysate at 15 µg
Lane 8:
K562 cell lysate at 15 µg
Lane 9:
MCF7 cell lysate at 15 µg
Lane 10:
Jurkat cell lysate at 15 µg
Lane 11:
SK-N-SH cell lysate at 15 µg
Lane 12:
THP-1 cell lysate at 15 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG HRP conjugate at 1/10000 dilution
Predicted band size: 47 kDa
false
- WB
Supplier Data
Western blot - Anti-DR5 antibody (AB8416)
Blocking buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-DR5 antibody (ab8416) at 1 µg/mL
All lanes:
Rat Skeletal Muscle at 15 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG HRP Conjugate at 1/10000 dilution
Predicted band size: 47 kDa
false
- WB
Supplier Data
Western blot - Anti-DR5 antibody (AB8416)
All lanes:
Western blot - Anti-DR5 antibody (ab8416) at 1 µg
Lane 1:
3T3/NIH cell lysate at 15 µg
Lane 2:
C2C12 cell lysate at 15 µg
Secondary
All lanes:
Goat anti-Rabbit IgG HRP conjugate at 1/10000 dilution
Predicted band size: 47 kDa
false
- WB
CiteAb
Western blot - Anti-DR5 antibody (AB8416)
DR5 western blot using anti-DR5 antibody ab8416. Publication image and figure legend from Yang, Y., Zhang, P., et al., 2018, Front Pharmacol, PubMed 29946260.
ab8416 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab8416 please see the product overview.
Effect of SCG on protein expression of TRAIL, DR5, FASL, FAS, IL-33, and caspase-3 in Con A-treated mice. (A) The expression of TRAIL. (B) The expression of DR5. (C) The expression of IL-33. (D) The expression of FASL. (E) The expression of FAS. (F) The expression of cleaved caspase-3. Data were expressed as mean ± SD (n = 3). **p < 0.01 compared with normal group; #p < 0.05, ##p < 0.01 compared with model group.
false
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DR5 plays a significant role in the regulation of apoptosis particularly in cancer cells. It is a component of the TRAIL receptor complex which includes several other death receptors like DR4. This complex formation allows DR5 to mediate apoptotic signals more efficiently. By controlling apoptosis DR5 helps maintain tissue homeostasis and prevents abnormal cell proliferation.
Pathways
DR5 is an important part of the TRAIL signaling pathway and the extrinsic apoptosis pathway. It connects with proteins like FADD and Caspase-8 essential in the apoptotic signaling cascade. By interacting with these proteins DR5 drives the progression of the apoptotic signal ensuring the removal of dysfunctional cells. Such pathways are vital for restraining tumor development and progression.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (64)
Recent publications for all applications. Explore the full list and refine your search
Animals : an open access journal from MDPI 15: PubMed40564269
2025
Applications
Unspecified application
Species
Unspecified reactive species
Regenerative therapy 30:1-8 PubMed40476159
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 6:102158 PubMed40449480
2025
Applications
Unspecified application
Species
Unspecified reactive species
Current issues in molecular biology 46:10880-10895 PubMed39451526
2024
Applications
Unspecified application
Species
Unspecified reactive species
World journal of gastrointestinal oncology 16:2716-2726 PubMed38994171
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 12: PubMed38791085
2024
Applications
Unspecified application
Species
Unspecified reactive species
FEBS open bio 13:2375-2388 PubMed37879960
2023
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceuticals (Basel, Switzerland) 16: PubMed37895919
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 14:1171293 PubMed37274104
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 19:2648-2662 PubMed37324949
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com